ALAna Lara-Garcia

Ana Lara-Garcia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ana Lara-Garcia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Axial Multicentric Osteosarcoma in an English Cocker Spaniel

    by B. Parzefall, S. De Decker, S. Carvalho, R. Terry, J. Leach, K.C. Smith, A. Lara-Garcia


  • Palliative Epineurotomy for Focal Radial Malignant Peripheral Nerve Sheath Tumor in a Dog

    by Andrew David Gibson, Emma Davies, Ana Lara-Garcia, Pilar Lafuente

    This case report describes the diagnosis of a peripheral nerve sheath tumor of the deep branch of the radial nerve distal to the elbow in a dog. The lesion was identified using computed tomography and ultrasonography and confirmed as sarcoma on histopathological analysis of incisional biopsies. Clinical signs dramatically improved following surgical biopsy before recurring three months later. Repeat epineurotomy of the deep branch of the radial nerve resulted in clinical improvement for a further month before signs once again returned. Epineurotomy as a palliative treatment for peripheral nerve sheath tumors has not been previously described, but may have a place in palliation of clinical signs in specific cases of peripheral nerve sheath tumors in which limb amputation is not an option.


  • Open Access

    T‐bet is required for survival and immunity to the intracellular pathogen Trypanosoma cruzi (T. cruzi)

    by Ronald B Smeltz, Ana Lara, Siqi Guo, Patricio Manque, Gregory A Buck

    The T‐box transcription factor expressed in T cells (T‐bet) is a critical regulator of T cell effector functions, particularly interferon gamma (IFN‐γ) production. We investigated the role of T‐bet in immunity to T. cruzi , an intracellular pathogen that causes Chagas disease in humans, and which requires both CD4 + and CD8 + T cells for successful control of the parasite. T‐bet‐deficient mice (T‐bet KO) infected with T. cruzi exhibited elevated blood parasitemia, progressive weight loss, and significant mortality. Infection was accompanied by an increase in tissue parasitism, as well as liver inflammation in T‐bet KO mice. FACS analysis revealed that CD4 + and CD8 + T cell differentiation were altered in spleens of T‐bet KO mice. In addition, there was a significant delay in the kinetics and magnitude of CD8 + T cell expansion in the blood of T‐bet KO mice. Despite an increase in T cell‐derived IL‐4 production, T cells from infected T‐bet KO mice still produced significant quantities of IFN‐γ, and serum IFN‐γ levels were elevated in T‐bet KO mice. These data demonstrate that T‐bet is required for immunity to T. cruzi , and suggests that mechanisms other than a Th1 to Th2 switch may be responsible for the increased susceptibility of T‐bet KO mice to T. cruzi infection.